Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE (DD-MM-YYYY) 2. REPORT TYPE 3. DATES COVERED (From -To)
00-10-2014 Technical15
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)DTRA/J9CBI
SPONSOR/MONITOR'S REPORT NUMBER(S)DTRA-TR-15-1
DISTRIBUTION / AVAILABILITY STATEMENTDisitribution Statement A: Approved for public release; distribution is unlimited.
SUPPLEMENTARY NOTESThis work was sponsored by the Defense Threat Reduction Agency.
ABSTRACT
Introduction and PurposeAccurate modeling of medical countermeasure efficacy against chemical, biological and radiological agents (CBR agents) is essential to understanding the vulnerability of our warfighters on the modern battlefield. In helping to calculate the benefit of countermeasures, modeling can inform data-driven purchasing decisions and logistical tradeoffs. In this study, Gryphon Scientific and Applied Research Associates, Inc. (ARA) have developed models to predict the efficacy of medical countermeasures in preventing casualties and reducing the severity and duration of illness caused by CBR agents. This report (prepared by ARA) is one of five, describing the medical countermeasure models constructed for this project. This volume focuses exclusively on the modeling approach, parameters, and calculations used for the medical countermeasure model (MCM) for cesium-137 (Cs-137) exposure. The composite model includes the appropriate parameters necessary for calculating the impact of Prussian Blue (PB) countermeasure treatment on Cs-137 exposure.This paper presents an inhalation exposure model for calculating the absorbed fraction of cesium-137 from a given air concentration. The paper also presents a biokinetic model for calculating the distribution of cesium-137 within the body, a Prussian Blue model for binding and removal of cesium-137 circulating through the gastrointestinal tract, and a radiation dose model for calculating the absorbed radiation dose in the whole body and to the critical organ, the red bone marrow. Each model approach is described and justified along with the assumptions and key parameters that are implemented in each model. The composite m...